Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
18-Mar-16 The CEO of Samsung Medison said he will achieve a rebound this year, wiping out recent sell-off rumors. One new product to assist with this goal is the PT10V, an IVD for animals, which can take up to 13 tests for animals at the same time. The CEO said “The animal medical device market is small but we see a new possibility.” [image: Business Korea]
Read More
18-Mar-16 KPJ Healthcare Bhd will spend close to MYR1.3 bn (USD324 mn) to build eight new hospitals in Malaysia over the next three to five years. This includes the Damansara 2 Specialist Hospital, to be developed at a cost of MYR376 mn (USD94 mn) and expected to open its doors in the fourth quarter of 2019. [image: The Star]
Read More
17-Mar-16 India’s largest doctor discovery platform Practo has launched services in Brazil, its sixth location. This makes it one of the few homegrown Indian consumer Internet startups to capitalize on high-growth global markets. Practo is already present in Singapore, the Philippines, Malaysia and Indonesia. [image: Practo]
Read More
17-Mar-16 More than 50 healthcare IT systems at Singapore's Ng Teng Fong General Hospital (NTFGH) and Jurong Community Hospital (JCH) have been integrated for an enhanced patient experience. After integrating both hospitals' clinical, operational and administrative systems, both facilities saw improvements in patient safety and delivered greater efficiency in these facilities. [image: Shutterstock]
Read More
17-Mar-16 The Indian government has banned around 344 fixed dosed combination drugs, including Pfizer's cough syrup Corex, Procter & Gamble's Vicks Action 500 Extra and Crocin Cold and Flu, citing their potential risks. [image: Sajjad Hussain / AFP / Getty Images]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com